Squarepoint’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-499,724
Closed -$1.62M 3808
2021
Q1
$1.62M Buy
+499,724
New +$1.81M 0.01% 1187
2019
Q1
Sell
-1,961
Closed -$58K 2502
2018
Q4
$58K Buy
+1,961
New +$89.1K ﹤0.01% 1840
2018
Q2
Sell
-3,669
Closed -$81K 2117
2018
Q1
$81K Buy
3,669
+1,615
+79% +$37K ﹤0.01% 1589
2017
Q4
$52K Sell
2,054
-620
-23% -$19.1K ﹤0.01% 2013
2017
Q3
$50K Sell
2,674
-1,548
-37% -$18K ﹤0.01% 1559
2017
Q2
$39K Buy
+4,222
New +$40.2K ﹤0.01% 1468

Other funds holding ASXC

Squarepoint's ASXC Position: Q2 2021 in Review

Squarepoint sold out of Asensus Surgical, Inc. (ASXC) in Q2 2021, closing a stake of 499,724 shares — an estimated $1.62M sold.

Squarepoint first reported a position in ASXC in Q2 2017 and held it in 6 quarters. The position peaked at $1.62M in Q1 2021. 119 funds tracked by Wall St. Rank hold ASXC as of Q2 2021.

  • Squarepoint reported no remaining Asensus Surgical, Inc. position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 499,724 Asensus Surgical, Inc. shares in Q2 2021, an estimated $1.62M.
  • Squarepoint first reported a position in Asensus Surgical, Inc. in Q2 2017 and held it in 6 quarters.
  • Squarepoint's Asensus Surgical, Inc. position peaked at $1.62M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.